BMC Cancer
- WANG LJ, Liu XY, Tan C, Wang ZW, et al
The impact of advanced glycation end products and their receptors on the
development and prognosis of colorectal cancer.
BMC Cancer. 2026 May 6. doi: 10.1186/s12885-026-16070.
- CAO M, Hao J, Jiang L
SPINK4 affected M2 macrophage polarization to promote colorectal cancer malignant
phenotype by PI3K/AKT pathway.
BMC Cancer. 2026 May 7. doi: 10.1186/s12885-026-16126.
Br J Cancer
- LIN SC, Tsai YC, Wang JL, Chin HJ, et al
Targeting NUDT21-mediated alternative polyadenylation of oncogenes ameliorates
colorectal cancer malignancy and metastasis.
Br J Cancer. 2026 May 6. doi: 10.1038/s41416-026-03451.
- CHENG HT, Seak CJ, Cheng CY, Huang SW, et al
The association between hospital frailty risk score and adverse inpatient
outcomes in older adults with colorectal cancer.
Br J Cancer. 2026 May 6. doi: 10.1038/s41416-026-03385.
- AL-KHAFAJI N, Steele F, Li H, Boyden H, et al
A comparison of overall survival from early-onset and late-onset colorectal
cancer stratified by TNM stage: a systematic review.
Br J Cancer. 2026 May 4. doi: 10.1038/s41416-026-03426.
Cancer
- LAWRENCE L
GLP-1 RAs could reduce risk of developing colorectal cancer.
Cancer. 2026;132:e70367.
- LAWRENCE L
Two trials bring new advances for patients with metastatic colorectal cancer:
First-line data show longer disease control in MSI-H/dMMR and higher responses in
BRAF V600E.
Cancer. 2026;132:e70368.
Cancer Res
- PATEL HV, Smith AE, Chan S, Gasendo JG, et al
The Farnesyl Transferase Inhibitor Darlifarnib (KO-2806) Resensitizes Relapsing
Tumors to RAS Inhibition.
Cancer Res. 2026;86:2273-2285.
Eur J Gastroenterol Hepatol
- RAFI R, Yasmin N, Ghani M, Siddiqui MN, et al
Performance of artificial intelligence software: EndoAngel, EndoAID, CAD-EYE, GI
Genius, and EndoScreener in adenoma detection: an extended network meta-analysis.
Eur J Gastroenterol Hepatol. 2026;38:706-716.
- OIWA K, Yamamura T, Nakamura M, Maeda K, et al
Total biopsy via endoscopic submucosal dissection is useful for the diagnosis of
neoplastic lesions in patients with ulcerative colitis.
Eur J Gastroenterol Hepatol. 2026 Feb 26. doi: 10.1097/MEG.0000000000003165.
- BAE JK, Park JJ, Kim SU, Youn YH, et al
Metabolic dysfunction-associated fatty liver disease is an independent risk
factor for advanced colorectal adenoma or cancer.
Eur J Gastroenterol Hepatol. 2026;38:632-638.
- SAEED A, Yousuf S, Zain A, Kashif M, et al
Comparison of precut endoscopic mucosal resection and endoscopic submucosal
dissection in the management of colorectal polyps: a systematic review and
meta-analysis.
Eur J Gastroenterol Hepatol. 2026;38:699-705.
Gastroenterology
- SAMNANI S, Forbes N
A Randomized Trial of Colonoscopy versus Fecal Immunochemical Testing versus
Usual Care in the Detection of Colorectal Cancer.
Gastroenterology. 2026 May 1:S0016-5085(26)06826.
Int J Cancer
- WURSCHI GW, Hinz A, Schneider M, Becker JN, et al
Oxaliplatin-induced neuropathy after total neoadjuvant therapy for rectal cancer:
Dose-response relationship and impact on quality of life.
Int J Cancer. 2026;159:198-209.
Int J Colorectal Dis
- LI X, Liang L, Liu ZH, Wang C, et al
Development and external validation of an interpretable multimodal deep learning
model for 5-year mortality in high-risk stage ii colorectal cancer.
Int J Colorectal Dis. 2026 May 2. doi: 10.1007/s00384-026-05132.
- OGAWA K, Miyamoto Y, Kawata A, Akiyama T, et al
Perioperative and oncological outcomes of extended surgery for colorectal cancer
in younger patients: a propensity score-matched study.
Int J Colorectal Dis. 2026 May 8. doi: 10.1007/s00384-026-05140.
J Clin Oncol
- GOGENUR I, Justesen TF, Tarpgaard LS, Bulut M, et al
Neoadjuvant Single-Cycle Pembrolizumab for Stage I-III MMR-Deficient Colon
Cancer: The RESET-C Trial.
J Clin Oncol. 2026 May 5:JCO2502274. doi: 10.1200/JCO-25-02274.
- SHARMA MR, Powderly J, Kuboki Y, Strickler JH, et al
Phase I Study of Telisotuzumab Adizutecan (Temab-A, ABBV-400), a Novel c-Met
Antibody-Drug Conjugate, in Patients With Late-Line Colorectal Cancer and
Advanced Solid Tumors.
J Clin Oncol. 2026 May 1:JCO2501525. doi: 10.1200/JCO-25-01525.
Lancet
- OBAYEMI JE, Agbedinu K, Kwakye G
Myopic medical harm: a man receives free colon cancer screening in Ghana.
Lancet. 2026;407:1676-1677.
Oncogene
- YANG MH, Sheth S, Shui B, Grabski IN, et al
The impact of K-Ras Gly12 mutants on homeostasis and tumorigenesis in the colonic
epithelium.
Oncogene. 2026;45:1828-1839.
Oncology
- CHOU CL, Hsu HP, Li WS, Lee SW, et al
Upregulated Claudin-18.2 Is a Poor Prognostic Indicator for Rectal Cancer
Patients Undergoing Preoperative Concurrent Chemoradiotherapy.
Oncology. 2026;104:552-563.
PLoS One
- CHERIF A, Coaston TN, Justo M, Yalzadeh D, et al
Association of early discharge and clinical outcomes following proctectomy for
patients with rectal cancer: A NRD analysis.
PLoS One. 2026;21:e0348125.
Proc Natl Acad Sci U S A
- YANG WD, Lu MR, Shen Q, Zhou PH, et al
Lactylated NAT10 contributes to elesclomol-triggered cuproptosis via the
NAT10/ac4C-DLAT-mRNA/DLAT positive feedback loop in CRC.
Proc Natl Acad Sci U S A. 2026;123:e2501185123.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016